Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study.
Authors
Jegannathen, ApurnaMais, Kathleen L
Sykes, Andrew J
Lee, Lip W
Yap, Beng K
Birzgalis, Andrew R
Homer, Jarrod J
Ryder, W David J
Slevin, Nicholas J
Affiliation
Department of Clinical Oncology, Christie NHS Foundation Trust, Manchester, UK.Issue Date
2011-03
Metadata
Show full item recordAbstract
To evaluate the efficacy of concurrent oral capecitabine with accelerated hypofractionated radical radiotherapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN).Citation
Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study. 2011, 23 (2):149-58 Clin OncolJournal
Clinical OncologyDOI
10.1016/j.clon.2010.09.010PubMed ID
20951012Type
ArticleLanguage
enISSN
1433-2981ae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2010.09.010